Karla Rewards

What Karla Rewards does

Shenqi Pharmaceutical (神奇制药), legally 9001诚信金沙(中国)股份有限公司, is a China-based pharmaceutical manufacturing holding company listed on the Shanghai Stock Exchange (A-share 600613; B-share 900904). Founded in 1983 in Guizhou Province and reorganized through asset restructurings in 2003 and 2013, the group consolidates five manufacturing subsidiaries — Shenqi Pharmaceutical, Jinqiao Pharmaceutical, Baiqiang Pharmaceutical, Junzhi Hall Pharmaceutical, and Shengshi Longfang Pharmaceutical — that together hold 76 NMPA drug approval numbers, 43 national invention patents, and 166 registered trademarks. The product portfolio spans eight therapeutic series including anti-tumor injectables, cardiovascular and three-high chronic disease medications, classic TCM cough and pediatric remedies (the Shenqi Wawa line), dermatological antifungals, and ethnic Miao medicine, supported by GMP-certified production lines and a national-level Miao Medicine Engineering Technology Center.

The company generates revenue primarily through one-time sales of prescription and OTC pharmaceutical products, with pricing governed by national pharmaceutical pricing policies, tendering processes, and distributor agreements rather than direct public disclosure. Go-to-market combines a direct sales force calling on hospitals and medical institutions across nearly 30 provinces with pharmacy retail distribution and wholesale partnerships, including a 2015 strategic alliance with Jiuzhou Tong Group. The Shawan Production and R&D Base — a 6 billion yuan investment with 30 production lines, 101 product varieties, and a designed capacity of 5.5 million pieces — received GMP compliance certification in 2021 and represents the central growth engine. The Shenqi brand has been listed on the World Brand Lab China Top 500 Brands for 11 consecutive years (2004-2014) with a 2014 brand value of 29.68 billion yuan.

The firm serves Chinese hospitals, clinics, pharmacies, and end-patient consumers requiring treatment across oncology, cardiovascular, respiratory, dermatological, and pediatric indications. It employs over 5,000 people and reports total assets exceeding 30 billion yuan, with the founding Shenqi Group retaining control of the listed entity.

Name

Karla Rewards

Legal name

9001诚信金沙(中国)股份有限公司

Website

https://karlarewards.com

Company type

Public

Founded year

1983

Operating status

Operating

Headcount range

1–10 employees

Short description

Shenqi Pharmaceutical (神奇制药) is a Shanghai-listed Chinese pharmaceutical manufacturer producing oncology, cardiovascular, respiratory, dermatology, pediatric, and ethnic Miao medicine products through five subsidiaries, distributing to hospitals and pharmacies across roughly 30 provinces.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industry

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• Pharmaceutical manufacturing
• Traditional Chinese medicine
• Anti-tumor medications
• Cardiovascular drugs
• Anti-fungal treatments

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing and Sales: The company generates revenue through the research, development, production, and sales of pharmaceutical products including anti-tumor drugs, cardiovascular medications, respiratory medications, cold and cough remedies, children's medications, anti-fungal treatments, and traditional Chinese ethnic medicine (Miao medicine) products. Revenue comes from the sale of prescription and OTC pharmaceutical products through a nationwide distribution network.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Karla Rewards (operates the website karlarewards.com hosting 9001诚信金沙/神奇制药) is a pharmaceutical investment holding company that develops, manufactures, and sells proprietary and generic medications across anti-tumor, cardiovascular, cold/cough/children's, anti-fungal, and traditional Chinese medicine (including Miao ethnic medicine) therapeutic categories through its five subsidiary manufacturers in Guizhou Province, China. The company distributes its products through a nationwide sales network covering nearly 30 provinces via hospitals, pharmacies, and wholesale partners.

Product overview

Karla Rewards (9001诚信金沙/神奇制药) is a pharmaceutical manufacturing holding company listed on the Shanghai Stock Exchange (stock code: 600613). The company operates as a specialized pharmaceutical manufacturer engaged in R&D, production, and sales of drugs spanning anti-tumor, cardiovascular, cold/cough/children's medications, and anti-fungal categories. The product portfolio is organized into eight main series: exclusive patented anti-tumor drugs, skin topical antibacterial products, three-high chronic disease management products, classic TCM cough treatments, classic tonic products, Miao medicine tendon-bone strengthening products, Shenqi Baby children's medications, and other specialty products. Key flagship products include 斑蝥酸钠维生素B6注射液 (anti-tumor injection), 珊瑚癣净 (anti-fungal skin solution), 杜仲双降袋泡剂 (chronic disease management), and 精乌颗粒 (tonic). The company has five subsidiary manufacturers: 神奇药业, 金桥药业, 柏强制药, 君之堂制药, and 盛世龙方制药.

Differentiator

Problem solved

Functional benefit

Products and services

• 斑蝥酸钠维生素B6注射液 (Cantharidin Sodium Vitamin B6 Injection)
• 珊瑚癣净 (Shanhu Xuanjing / Coral Ringworm Net)
• 复方珊瑚姜溶液尿素咪康唑软膏复合制剂 (Compound Coral Ginger Solution + Miconazole Nitrate Ointment Combo / Pate Special Kit)
• 杜仲双降袋泡剂 (Duzhong Shuangjiang Tea Bag / Eucommia Double-Reduction Sachet)
• 精乌颗粒 (Jingwu Granules)
• 神奇娃娃儿药系列 (Shenqi Wawa Children's Medication Series)
• 苗药强筋健骨系列 (Miao Medicine Tendon-Bone Strengthening Series)
• 银丹心泰滴丸 (Yindan Xintai Dripping Pills)
• 中药经典止咳系列 (Classic TCM Cough Treatment Series)
• 三高慢病产品系列 (Three-High Chronic Disease Management Product Series)
• 独家专利抗肿瘤药系列 (Exclusive Patented Anti-tumor Drug Series)

Quantifiable outcome

• Shenqi brand ranked 457th in China Top 500 brands with brand value of 29.68 billion yuan
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• 九州通医药集团 (Jiuzhou Tong Medical Group)flagshipStrategic or Co-development Partner · 26 April 2015Shenqi Pharmaceutical signed a strategic cooperation agreement with Jiuzhou Tong Group on April 26, 2015, in Guiyang. This partnership was described by the industry as a high-end cooperation for platform mutual benefit. Jiuzhou Tong is one of China's largest pharmaceutical distribution companies, and this alliance enables Shenqi to leverage Jiuzhou Tong's nationwide logistics and distribution network for its pharmaceutical products.

Scale indicators12 records

Recent moves8 records

Expansion highlights4 records

Broad incumbents

• Shanghai Pharmaceuticals Holding: A top-tier Chinese pharmaceutical conglomerate with extensive manufacturing, distribution, and R&D operations across TCM, chemical drugs, and biologics. As a much larger incumbent, it competes with Shenqi in TCM and OTC but at a far broader scale.
• Jiangsu Hengrui Pharmaceuticals: China's largest innovative drug company with a strong focus on oncology, injectable formulations, and patented pharmaceuticals. Adjacent competitor to Shenqi's anti-tumor injectable franchise but with far greater R&D scale and innovation pipeline.

Direct peers

• Pien Tze Huang Pharmaceutical: A Fujian-based traditional Chinese medicine manufacturer known for its flagship proprietary formula, exclusive product positioning, and high brand recognition. Comparable to Shenqi's exclusive-product model and TCM heritage.
• Tianjin Zhongxin Pharmaceutical Group: A Tianjin-based TCM manufacturer known for iconic branded products (e.g., 速效救心丸) and broad chronic-disease coverage. Comparable to Shenqi in branded cardiovascular/chronic-disease TCM portfolio.
• Yunnan Baiyao Group: A major Chinese pharmaceutical manufacturer with a deep traditional Chinese medicine (TCM) heritage, broad OTC and prescription portfolio, and nationwide distribution. Closely comparable to Shenqi in being a TCM-rooted, multi-category, nationally distributed pharma group.
• Beijing Tongrentang: One of China's most iconic TCM brands with a wide portfolio of traditional medicines and a national pharmacy chain. Comparable to Shenqi in TCM heritage, brand recognition, multi-product portfolio, and emphasis on chronic-disease and tonic indications.
• Guangzhou Baiyunshan Pharmaceutical Holdings: A diversified Chinese pharmaceutical group combining TCM, chemical drugs, and healthcare products with national distribution. Comparable to Shenqi across both TCM and chemical drug manufacturing, branded consumer health, and broad therapeutic coverage.
• Livzon Pharmaceutical Group: A Chinese pharmaceutical group with a diversified portfolio in chemical drugs, TCM, and API manufacturing. Comparable to Shenqi in combining TCM and modern pharma, owning exclusive SKUs, and operating multiple manufacturing subsidiaries.
• China Resources Sanjiu Medical & Pharmaceutical: A leading Chinese OTC and TCM manufacturer with a focus on self-medication brands, pediatric and chronic-disease categories. Closely matches Shenqi's OTC orientation, branded children/cough franchises, and national distribution.
• Jiangzhong Pharmaceutical: A TCM-focused Chinese pharmaceutical company with strong consumer health brands in gastrointestinal and tonic categories. Comparable to Shenqi in TCM emphasis, branded OTC franchise, and focus on classic/tonic formulations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/karlarewards
• Facebookfacebook.com/karlarewards
• LinkedInlinkedin.com/company/karlarewards

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karla Rewards